Clonal expansion of Epstein-Barr virus (EBV)-infected γδ T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions

International Journal of Hematology

Volumn 96, Issue 4, 2012, Pages 443-449

  Wada, Taizo ^a   Toga, Akiko ^a   Sakakibara, Yasuhisa ^a   Toma, Tomoko ^a   Hasegawa, Minoru ^a   Takehara, Kazuhiko ^a   Shigemura, Tomonari ^b   Agematsu, Kazunaga ^b   Yachie, Akihiro ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

T cells; Clonal proliferation; Epstein Barr virus; Hydroa vacciniforme

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ARTICLE; CASE REPORT; CELL EXPANSION; CELL POPULATION; DERMATITIS HERPETIFORMIS; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GAMMA DELTA T LYMPHOCYTE; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHOCYTIC INFILTRATION; SKIN BIOPSY;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; HYDROA VACCINIFORME; IMMUNOPHENOTYPING; JAPAN; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES;

EID: 84868145293     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-012-1156-0     Document Type: Article

References (27)

1. Hislop AD, Taylor GS, Sauce D, Rickinson AB. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol. 2007;25:587-617. (Pubitemid 46697918)
2. Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES. Epstein- Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol. 2009;20:1472-82.
3. Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, Imai S, Ohga S, Kanegane H, Tsuchiya S, Morio T, Mori M, Yokota S, Imashuku S. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol. 2005;80:64-9. (Pubitemid 41254271)
4. Kimura H, Hoshino Y, Hara S, Sugaya N, Kawada J, Shibata Y, Kojima S, Nagasaka T, Kuzushima K, Morishima T. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection. J Infect Dis. 2005;191:531-9. (Pubitemid 40216668)
5. Gupta G, Man I, Kemmett D. Hydroa vacciniforme: a clinical and follow-up study of 17 cases. J Am Acad Dermatol. 2000;42: 208-13. (Pubitemid 30469616)
6. Chen HH, Hsiao CH, Chiu HC. Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma. Br J Dermatol. 2002;147:587-91.
7. Iwatsuki K, Xu Z, Takata M, Iguchi M, Ohtsuka M, Akiba H, Mitsuhashi Y, Takenoshita H, Sugiuchi R, Tagami H, Kaneko F. The association of latent Epstein-Barr virus infection with hydroa vacciniforme. Br J Dermatol. 1999;140:715-21. (Pubitemid 29191396)
8. Cho KH, Lee SH, Kim CW, Jeon YK, Kwon IH, Cho YJ, Lee SK, Suh DH, Chung JH, Yoon TY, Lee SJ. Epstein-Barr virusassociated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases. Br J Dermatol. 2004;151:372-80.
9. Iwatsuki K, Satoh M, Yamamoto T, Oono T, Morizane S, Ohtsuka M, Xu ZG, Suzuki D, Tsuji K. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol. 2006;142:587-95. (Pubitemid 43727549)
10. Kimura H, Miyake K, Yamauchi Y, Nishiyama K, Iwata S, Iwatsuki K, Gotoh K, Kojima S, Ito Y, Nishiyama Y. Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases. J Infect Dis. 2009;200:1078-87.
11. Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, Naoe T, Esaki S, Kikuta A, Sawada A, Kawa K, Ohshima K, Nakamura S. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119:673-86.
12. Hirai Y, Yamamoto T, Kimura H, Ito Y, Tsuji K, Miyake T, Morizane S, Suzuki D, Fujii K, Iwatsuki K. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virusinfected γδ T cells. J Invest Dermatol. 2012;132:1401-8.
13. Tanaka C, Hasegawa M, Fujimoto M, Iwatsuki K, Yamamoto T, Yamada K, Kawa K, Saikawa Y, Toga A, Mase S, Wada T, Takehara K, Yachie A. Phenotypic analysis in a case of hydroa vacciniforme-like eruptions associated with chronic active Epstein-Barr virus disease of γδ T cells. Br J Dermatol. 2012; 166:216-8.
14. Toga A, Wada T, Sakakibara Y, Mase S, Araki R, Tone Y, Toma T, Kurokawa T, Yanagisawa R, Tamura K, Nishida N, Taneichi H, Kanegane H, Yachie A. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis. J Infect Dis. 2010;201: 1923-32.
15. de Villartay JP, Lim A, Al-Mousa H, Dupont S, Dechanet-Merville J, Coumau-Gatbois E, Gougeon ML, Lemainque A, Eidenschenk C, Jouanguy E, Abel L, Casanova JL, Fischer A, Le Deist F. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest. 2005;115: 3291-9. (Pubitemid 41567594)
16. Ehl S, Schwarz K, Enders A, Duffner U, Pannicke U, Kuhr J, Mascart F, Schmitt-Graeff A, Niemeyer C, Fisch P. A variant of SCID with specific immune responses and predominance of γδ T cells. J Clin Invest. 2005;115:3140-8. (Pubitemid 41567578)
17. Wada T, Schurman SH, Otsu M, Garabedian EK, Ochs HD, Nelson DL, Candotti F. Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc Natl Acad Sci USA. 2001;98:8697-702. (Pubitemid 32678090)
18. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, van Krieken JH, Droese J, Gonzalez D, Bastard C, White HE, Spaargaren M, Gonzalez M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-317. (Pubitemid 38072572)
19. Quintanilla-Martinez L KH, Jaffe ES. EBV-positive T-cell lymphoproliferative disorders of childhood. Geneva, Switzerland: World Health Organization, 2008.
20. Dechanet J, Merville P, Lim A, Retiere C, Pitard V, Lafarge X, Michelson S, Meric C, Hallet MM, Kourilsky P, Potaux L, Bonneville M, Moreau JF. Implication of γδ T cells in the human immune response to cytomegalovirus. J Clin Invest. 1999;103: 1437-49. (Pubitemid 29535500)
21. O'Brien RL, Roark CL, Jin N, Aydintug MK, French JD, Chain JL, Wands JM, Johnston M, Born WK. γδ T-cell receptors: functional correlations. Immunol Rev. 2007;215:77-88. (Pubitemid 46212231)
22. Morita CT, Parker CM, Brenner MB, Band H. TCR usage and functional capabilities of human gamma delta T cells at birth. J Immunol. 1994;153:3979-88. (Pubitemid 24322565)
23. Parker CM, Groh V, Band H, Porcelli SA, Morita C, Fabbi M, Glass D, Strominger JL, Brenner MB. Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J Exp Med. 1990;171:1597-612. (Pubitemid 20167553)
24. Oyoshi MK, Nagata H, Kimura N, Zhang Y, Demachi A, Hara T, Kanegane H, Matsuo Y, Yamaguchi T, Morio T, Hirano A, Shimizu N, Yamamoto K. Preferential expansion of Vγ9-JγP/Vδ2-Jδ3 γδ T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection. Am J Pathol. 2003;162:1629-38. (Pubitemid 36512846)
25. Komori HK, Meehan TF, Havran WL. Epithelial and mucosal gamma delta T cells. Curr Opin Immunol. 2006;18:534-8. (Pubitemid 44311446)
26. Verneuil L, Gouarin S, Comoz F, Agbalika F, Creveuil C, Varna M, Vabret A, Janin A, Leroy D. Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up. Br J Dermatol. 2010;163:174-82.
27. Yoshimasu T, Nishide T, Seo N, Hiroi A, Ohtani T, Uede K, Furukawa F. Susceptibility of T cell receptor-alpha chain knockout mice to ultraviolet B light and fluorouracil: a novel model for drug-induced cutaneous lupus erythematosus. Clin Exp Immunol. 2004;136:245-54. (Pubitemid 38543442)